Passive Leg Raising Test to Predict Hypotension During Induction of Anesthesia in Patients Undergoing Cardiac Surgery
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jun 14, 2010
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
In this randomized controlled clinical trial, the investigators hypothesized that passive leg raising induced changes in hemodynamic parameters could predict the hypotension during anesthesia induction. To evaluate this, before anesthesia, the investigators will conduct passive leg raising test. At first, the patient's trunk was elevated 45 degrees for the first set of measurements. Then, the lower limbs were raised to a 45° angle while the patient's trunk was lowered to a supine position to measure peak CO (usually within 1-2 min). Hemodynamic profiles planned to be measured are mean arter...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • adult patients undergoing elective cardiac surgery
- Exclusion Criteria:
- • arrhythmias
- • documented peripheral artery disease
- • severe pulmonary disease
- • heart failure
- • unstable angina
- • preoperative use of inotropics or mechanical assist device
- • use of angiotensin converting enzyme inhibitors
- • expected intubation difficulty or gastric reflux disease
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Yunseok Jeon, M.D
Study Director
Seoul National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials